| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.75B | -12.8% |
| R&D Expense | $28.9M | -12.0% |
| SG&A Expense | $411.1M | -4.4% |
| Operating Income | -$395.0M | -255.2% |
| Interest Expense | $89.6M | -3.0% |
| Pre-tax Income | -$432.3M | -323.6% |
| Income Tax | $46.1M | -15.3% |
| Net Income | -$478.4M | -444.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.28B | +95.5% |
| Short-term Investments | $417.7M | -47.8% |
| Accounts Receivable | $233.9M | -1.0% |
| Inventory | $167.2M | +36.0% |
| Current Assets | $2.14B | +8.9% |
| Total Assets | $5.20B | +7.9% |
| Current Liabilities | $741.9M | +20.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $452.6M | -16.0% |
| Capital Expenditures | $190.1M | -20.6% |
| Investing Cash Flow | $171.3M | +181.9% |
| Financing Cash Flow | -$3.6M | +96.5% |
| Free Cash Flow | $262.4M | -12.4% |
| Long-term Debt |
| $1.50B |
| +0.1% |
| Total Liabilities | $3.52B | +31.9% |
| Stockholders' Equity | $1.61B | -21.4% |